Pasar al contenido principal

DIAGNOSTICO POR IMAGEN MOLECULAR: INVESTIGACION BASICA Y DESARROLLO TRASLACIONAL

RED2022-134299-T

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Redes Investigación /Redes Excelencia
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Periodic table screening for enhanced positive contrast in MRI and in vivo uptake in glioblastoma

  • Herraiz-Pérez, Aitor
  • Morales, María Del Puerto
  • Martínez-Parra, Lydia
  • Arias-Ramos, Nuria
  • López-Larrubia, Pilar
  • Gutiérrez, Lucía
  • Mejías, Jesús
  • Díaz-Ufano, Carlos
  • Ruíz-Cabello, Jesús
  • Herranz, Fernando
The quest for nanomaterial-based imaging probes that can provide positive contrast in MRI is fueled by the necessity of developing novel diagnostic applications with potential for clinical translation that current gold standard probes cannot provide. Although interest in nanomaterials for positive contrast has increased in recent years, their study is less developed than that of traditional negative contrast probes in MRI. In our search for new magnetic materials with enhanced features as positive contrast probes for MRI, we decided to explore the chemical space to comprehensively analyze the effects of different metals on the performance of iron oxide nanomaterials already able to provide positive contrast in MRI. To this end, we synthesized 30 different iron oxide-based nanomaterials. Thorough characterization was performed, including multivariate analysis, to study the effect of different variables on their relaxometric properties. Based on these results, we identified the best combination of metals for in vivo imaging and tested them in different experiments. First, we tested its performance on magnetic resonance angiography using a concentration ten times lower than that clinically approved for Gd. Finally, we studied the capability of these nanomaterials to cross the affected blood–brain barrier in a glioblastoma model. The results showed that the selected nanomaterials provided excellent positive contrast at large magnetic field and were able to accumulate at the tumor site, highlighting the affected tissue., This study was supported by a grant for predoctoral contracts for the training of PhD students from the Spanish Ministry of Science and Innovation (grant number PRE2020-091870), associated with the National Plan project PID2019-104059RB-100. We acknowledge funding from the Spanish Ministry of Science and Innovation (PID2021-123238OB-100, PDC2022-133493-100, RED2022-134299-T), La Caixa Foundation (Health Research Call 2020: HR20-00075), the Basque Government, R&D Projects in Health (Grant no. 2022333041) and Comunidad de Madrid (P2022/BMD-7333). Conexión Nanomedicina CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset -Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Files List: Figure 1 F1b_Particle size histogram (b) of the synthesized nanoparticles Figure 2 F2a_blue XRD pattern of the synthesized nanoparticles F2a_red ticks corresponding to the tetragonal NaDy(WO4)2 (25-829 PDF file). F2b_FTIR spectrum of the tetragonal NaDy(WO4)2 nanoparticles F2c_TGA curve of the tetragonal NaDy(WO4)2 nanoparticles. Figure 3 F3_MES_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 0 h. F3_MES_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 24 h. F3_MES_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 48 h. F3_MES_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 72 h. F3_Saline_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 0 h. F3_Saline_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 24 h. F3_Saline_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 48 h. F3_Saline_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 72 h. F3_Water_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 0 h. F3_Water_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 24 h. F3_Water_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 48 h. F3_Water_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 72 h. Figure 5 F5c_Percentage of dead cells obtained from live-dead analysis F5d_black_Negative and positive control for live-dead analysis F5d_cyan_total number of cells per well obtained from live-dead analysis Figure 6 F6_black_negative and positive control for MTT assay F6_cyan_Mitochondrial activity of cells exposed to increasing concentration of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles evaluated by MTT assay Figure 7 F7c_EDX spectrum taken from the region marked with a white square in Figure 7 (a). Figure 8 F8_left_Viability of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h F8_right_Brood size (right) of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h Figure 9 F9a_blue_Relaxation rates 1/T1 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9a_red_Relaxation rates 1/T1 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_blue_Relaxation rates 1/T2 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_red__Relaxation rates 1/T2 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles Figure 11 F11_green_X-ray attenuation values (in Hounsfield units, HU) of NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water F11_ red_X-ray attenuation values (in Hounsfield units, HU) of iohexol dispersed in water, Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020-118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Open Access Article. Published on 10 October 2025. Downloaded on 10/10/2025 10:25:41 AM. This article is licensed under a which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanoparticle to Nanoparticle Bioorthogonal Detection of Atherosclerosis

  • Muñoz-Hernando, María
  • Nogales, Paula
  • Rodríguez-San Pedro, Andrea
  • Ibañez, Marta
  • Morcillo, Miguel Ángel
  • González-Cintado, Leticia
  • Bentzon, Jacob F
  • Herranz, Fernando
In vivo identification and characterization of atherosclerosis is a promising approach for the development of novel therapies and personalized treatments. Among the methods for this in vivo identification, the use of pretargeted imaging shows very large probe uptakes and excellent selectivity. However, this approach relies on the use of antibodies which may limit their usability. In this study, we introduce a pretargeting imaging approach for atherosclerosis detection using PET that only employs nanomaterials. Here we develop the concept of nanoparticle-to-nanoparticle pretargeted imaging for atherosclerosis. Sphingomyelin solid lipid nanoparticles (sphNP) functionalized with trans-cyclooctene (TCO) were used as targeting agents and accumulated in atherosclerotic plaques. This was followed by the injection of 68Ga-doped nanotracers functionalized with tetrazine ([68Ga]Ga-IONP-Tz), which binds to the accumulated sphNP-TCO via bioorthogonal click chemistry. In vivo PET imaging showed clear uptake in the aortic arch of mice receiving the full pretargeting approach, while the control groups showed no significant signal. This nanoparticle-based pretargeting strategy enables noninvasive PET imaging of atherosclerosis without using antibodies. This approach expands the use of bioorthogonal imaging and may have potential for targeted drug delivery to atherosclerotic plaques., We acknowledge funding from the Spanish Ministry of Science and Innovation (PDC2022−133493−100, RED2022−134299- T, PID2019−104059RB-100), Comunidad de Madrid (P2022/BMD-7333), Conexion Nanomedicina CSIC, and European Research Council under the European Union’s Horizon 2020 research and innovation program (grant no. 866240). CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (grant CEX2020−001041-S funded by MICIN/ AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator

  • Herraiz-Pérez, Aitor
  • Rodríguez-San Pedro, Andrea
  • Casquero-Veiga, Marta
  • Cossío, Unai
  • Arias-Ramos, Nuria
  • Gutiérrez, Lucía
  • Romero-Sanz, Eduardo
  • Luján-Rodríguez, Víctor Manuel
  • Cerón, Carlos
  • Oteo, Marta
  • González-Paredes, Ana
  • López-Larrubia, Pilar
  • Rosales, Rafael T. M. de
  • Cortés-Canteli, Marta
  • Morcillo, Miguel A.
  • Ruíz-Cabello, Jesús
  • Pellico, Juan
  • Herranz, Fernando
Data availability: The datasets generated and/or analyzed during the current study are very large and complex, and are not easily shared via public repositories, but they are fully available from the corresponding author upon reasonable request., Radiopharmaceuticals that combine diagnostic and therapeutic isotopes are at the forefront of novel cancer treatments. A crucial element is the method of attaching radioisotopes to biomolecules using chelator-based techniques that are widely used clinically. Selection from available chelators is essential because this choice influences the physicochemical and biological characteristics of the final radiopharmaceutical. Numerous chelators exist because none fulfill all ideal conditions: rapid and complete binding to radiometals at low concentrations and with metallic impurities, high thermodynamic and kinetic stability in vivo, easy bioconjugation, and, key for this work, achieving these for many radiometals from the growing list of medical isotopes. We demonstrate how nanotechnology may change this. Ten nano-radiotracers were synthesized, incorporating radiometals such as 68Ga, 64Cu, 89Zr, 99mTc, 201Tl, 111In, 67Ga, 177Lu, 223Ra, and 225Ac into the nanoparticle core. The versatility of the platform was demonstrated through proof-of-concept experiments, including passive targeting in glioblastoma, active targeting of thrombosis, intratumoral radiotherapy in glioblastoma, and renal clearance optimization. This nanotracer addresses traditional challenges in radiopharmaceutical development, offering a single platform with consistent physicochemical and biological properties regardless of the radioisotope used for robust diagnostic and therapeutic applications., The authors thank funding from the Spanish Ministry of Science and Innovation (PDC2022-133493-100, RED2022-134299-T, PID2019-104059RB-100), Comunidad de Madrid (P2022/BMD-7333) and Conexion Nanomedicina CSIC. The authors thank the Sebastián Cerdán Biomedical NMR Facility of IIBM for their technical support. J. P. acknowledges financial support from the Ramon y Cajal program (Grant No. RYC2023-043157-I) funded by the MCIN/AEI/10.13039/501100011033 and the ESF “Investing in your future”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Vascular-Immune Cells Crosstalk and Microenvironment in Pulmonary Hypertension

  • Navarro-Llinares, Lola
  • García-León, Bertha
  • de la Bastida-Casero, Laura
  • Oliver, Eduardo
Pulmonary hypertension is a disease of the lung vasculature, which eventually leads to heart dysfunction. Despite the advances in the discovery and development of new treatments, most of them are aimed to palliate symptoms. Thus, it is crucial to identify novel potential targets directly acting on vascular remodeling. Further understanding of this pathological event is needed to completely describe the disease's mechanisms and effectively generate therapeutical strategies able to cure the disease. Here, we propose an integrative perspective of studying pulmonary hypertension based on the interactions between the vascular cells and their surroundings. This review describes the crosstalk between vascular cells and immune cells in the diseased vasculature, highlighting the central role of this axis and the importance of healthy cell-to-cell communication. Furthermore, we discuss the possibility of considering the pulmonary microenvironment as a key pathological factor in pulmonary hypertension, This work was supported by funding from Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación MCIN/ AEI/10.13039/501100011033 and by “ERDF A way of making Europe” (PID2021- 123167OB- I00, PID2024- 159407OB- I00 and RED2022- 134299- T), CSIC Talent Attraction program (20222AT010) and Ayudas especiales para la preparación de proyectos (2025AEP161), CIBERCV- CIBERNED collaborative funds (CV24PI04/2024), La Marató de TV3 Foundation (202336- 30- 31) and Ayudas para la investigación de la Fundación contra la Hipertensión Pulmonar. L.B.- C. was a recipient of a predoctoral fellowship from Comunidad de Madrid (PIPF- 2022/SAL- GL- 24824). B.G.- L. was a recipient of a Severo Ochoa FPI predoctoral fellowship from Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación (PRE2022- 104403), Peer reviewed, Sin experimentacion animal ni uso de NAMs
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Periodic table screening for enhanced positive contrast in MRI and <i>in vivo</i> uptake in glioblastoma

  • Herraiz, Aitor
  • Morales, M. Puerto
  • Martínez-Parra, Lydia
  • Arias-Ramos, Nuria
  • López-Larrubia, Pilar
  • Gutiérrez, Lucía
  • Mejías, Jesús
  • Díaz-Ufano, Carlos
  • Ruiz-Cabello, Jesús
  • Herranz, Fernando
The quest for nanomaterial-based imaging probes that can provide positive contrast in MRI is fueled by the necessity of developing novel diagnostic applications with potential for clinical translation that current gold standard probes cannot provide. Although interest in nanomaterials for positive contrast has increased in recent years, their study is less developed than that of traditional negative contrast probes in MRI. In our search for new magnetic materials with enhanced features as positive contrast probes for MRI, we decided to explore the chemical space to comprehensively analyze the effects of different metals on the performance of iron oxide nanomaterials already able to provide positive contrast in MRI. To this end, we synthesized 30 different iron oxide-based nanomaterials. Thorough characterization was performed, including multivariate analysis, to study the effect of different variables on their relaxometric properties. Based on these results, we identified the best combination of metals for in vivo imaging and tested them in different experiments. First, we tested its performance on magnetic resonance angiography using a concentration ten times lower than that clinically approved for Gd. Finally, we studied the capability of these nanomaterials to cross the affected blood–brain barrier in a glioblastoma model. The results showed that the selected nanomaterials provided excellent positive contrast at large magnetic field and were able to accumulate at the tumor site, highlighting the affected tissue
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator

  • Herraiz, Aitor
  • Rodríguez-San-Pedro, Andrea
  • Casquero-Veiga, Marta
  • Cossío, Unai
  • Arias-Ramos, Nuria
  • Gutiérrez, Lucía
  • Romero-Sanz, Eduardo
  • Luján-Rodríguez, Víctor Manuel
  • Cerón, Carlos
  • Oteo, Marta
  • González-Paredes, Ana
  • López-Larrubia, Pilar
  • Rosales, Rafael T. M. de
  • Cortes-Canteli, Marta
  • Morcillo, Miguel A.
  • Ruiz-Cabello, Jesús
  • Pellico, Juan
  • Herranz, Fernando
Radiopharmaceuticals that combine diagnostic and therapeutic isotopes are at the forefront of novel cancer treatments. A crucial element is the method of attaching radioisotopes to biomolecules using chelator-based techniques that are widely used clinically. Selection from available chelators is essential because this choice influences the physicochemical and biological characteristics of the final radiopharmaceutical. Numerous chelators exist because none fulfill all ideal conditions: rapid and complete binding to radiometals at low concentrations and with metallic impurities, high thermodynamic and kinetic stability in vivo, easy bioconjugation, and, key for this work, achieving these for many radiometals from the growing list of medical isotopes. We demonstrate how nanotechnology may change this. Ten nano-radiotracers were synthesized, incorporating radiometals such as 68Ga, 64Cu, 89Zr, 99mTc, 201Tl, 111In, 67Ga, 177Lu, 223Ra, and 225Ac into the nanoparticle core. The versatility of the platform was demonstrated through proof-of-concept experiments, including passive targeting in glioblastoma, active targeting of thrombosis, intratumoral radiotherapy in glioblastoma, and renal clearance optimization. This nanotracer addresses traditional challenges in radiopharmaceutical development, offering a single platform with consistent physicochemical and biological properties regardless of the radioisotope used for robust diagnostic and therapeutic applications.